About this trial
This study investigates whether administering TAP blocks pre-incision provides superior postoperative pain control and reduces opioid use along with other medications compared to post-incision administration in patients undergoing elective abdominal surgeries.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged between 18 and 65 years
Scheduled for elective bariatric surgery or other elective general abdominal surgeries
Proficient in English sufficient to understand study procedures and communicate effectively
Capable of providing informed consent
Disqualifiers
Individuals under 18 years of age (minors)
Pregnant individuals
Prisoners
Individuals with cognitive impairments or otherwise unable to provide informed consent independently
Trial design
Parallel
Treatments tested in this trial
TAP Block
Other interventionthe TAP block is a regional anesthesia technique that targets the somatic nerves supplying the anterior abdominal wall.
Treatment groups
Trial outcomes
Primary outcomes
Mean change in opioid consumption (MME) from index procedure to 90 days post-op
Opioid dosage quantities will be measured in morphine milligram equivalents (MME)
Change in Pain Scores from index procedure on a numerical rating scale
Patient-reported pain on a scale of 1-10.
Secondary outcomes
1. Total Opioid Consumption in MME from Surgery to 90 Days Postoperatively
Sum of all opioid use from surgery to 90 days, in MME
Patient Satisfaction Score with Postoperative Pain Management at Discharge
Satisfaction score using a 5-point Likert scale survey before discharge.
Use of Non-Opioid Analgesics within 72 Hours
Count of participants receiving non-opioid pain medications (e.g. acetaminophen, NSAIDs) within 72 hours post-op, including amount and type.
Number of Participants with TAP Block-Related Adverse Events
Incidence of adverse events (e.g. local anesthetic toxicity, infection, bleeding) related to TAP block.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.